BDR Pharmaceutical launched the first generic of a key prostrate cancer drug – Apalutamide under the brand name Apatide in India at one-third the price of the innovator brand.
Raheel Shah, Director Business Development, BDR Group said that the product will be available across India in strengths of 60mg in packs of 60 tablets and 120 tablets. “Typically a patient is put on this drug for two months with a gap of one week in between the two months,” Shah said.
The price for a bottle of 60 tablets is Rs 22,500 and for a bottle of 120 tablets is